TRPV1 and neoplasm: Here, we found that the TRPV1 is overexpressed by NANOG in cisplatin-resistant tumor cells and mediates Ca2+ influx and subsequent increases in autophagic EGF secretion, which activates the EGFR-AKT signaling pathway consequently contributing to cisplatin resistance.